Your session is about to expire
← Back to Search
Light Therapy for Prostate Cancer
Study Summary
This trial will study whether light exposure can help prevent fatigue in prostate cancer patients during radiation therapy, and how it works.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You can understand and communicate in English.You are taking medication that makes you more sensitive to light.You work a non-traditional schedule that includes night shifts.You are able to connect to the internet.You have had seasonal affective disorder in the past.You have been diagnosed with sleep apnea, restless legs, or other sleep disorders that can cause fatigue, but not if you only have trouble sleeping (insomnia).You have used light therapy in the past.You have a history of long-term tiredness or exhaustion.You have a pre-existing medical condition that may interfere with the study, such as severe anemia (low red blood cell count).You have a medical or mental health condition that may cause fatigue, aside from the fatigue caused by cancer or its treatment.You have a history of bipolar disorder or manic episodes.You are going to start radiation therapy for prostate cancer.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: Intervention light
- Group 2: Comparison light
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
What is the current enrolment size for this experiment?
"Affirmative. As indicated on clinicaltrials.gov, the active recruitment of participants for this medical trial commenced on December 12th 2018 and was most recently updated in February 7th 2022. There is a target quota of 60 individuals across one location."
Are researchers presently enrolling participants for this clinical investigation?
"This research project is in the process of recruiting participants, as indicated on clinicaltrials.gov. The initial posting was made on December 12th 2018 with a subsequent update issued February 7th 2022."
What are the objectives of this investigation?
"The primary metric of this study is Fatigue, measured at Baseline. Secondary objectives include Sexual and Urinary Functioning (using the American Urological Association symptom index & Sexual Adjustment Questionnaire), Sleep Quality (assessed through Pittsburgh Sleep Quality Index) and Depressed Mood (as indicated by Center for Epidemiologic Studies Depression Scale). Higher scores are connected to increased levels of symptoms being present."
Share this study with friends
Copy Link
Messenger